• Home
  • NEW DAY MEDICINE
  • 6(56)2023
  • 60 -6 (56) 2023 — Sh.J. Teshaev, S.A.Oblokulova — COMPARATIVE CHARACTERISTICS OF MORPHOMETRIC PARAMETERS OF THE LIVER IN SPINAL CORD INJURY

60 -6 (56) 2023 — Sh.J. Teshaev, S.A.Oblokulova — COMPARATIVE CHARACTERISTICS OF MORPHOMETRIC PARAMETERS OF THE LIVER IN SPINAL CORD INJURY

COMPARATIVE CHARACTERISTICS OF MORPHOMETRIC PARAMETERS OF THE LIVER IN SPINAL CORD INJURY

Sh.J. Teshaev Bukhara State Medical Institute named after Abu Ali ibn Sina

S.A.Oblokulova Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Тhe search for treatment methods that minimize hepatic and other systemic changes after spinal cord injury will in the future be able to offer a new approach to improving the overall health, well-being, and life expectancy of people with spinal cord injury.

Keywords: morphometry, liver, morphology, craniocerebral injury

First page

351

Last page

354

LIST OF REFERENCES:

  1. Almad, A., and McTigue, D.M. Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord. J. Comp. Neurol. (2010) 518:785-799.
  2. Almad, A., Lash, A.T., Wei, P., Lovett-Racke, A.E., and McTigue, D.M. The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice. Exp. Neurol. (2011) 232:309-317.
  3. Bandaru, V.V., Mielke, M.M., Sacktor, N., McArthur, J.C., Grant, I. Letendre, S., Chang, L., Wojna, V., Pardo, C., Calabresi, P., Munsaka, S., and Haughey, N.J. A lipid storage-like disorder contrib- utes to cognitive decline in HIV-infected subjects. Neurology (2013) 81:1492-1499.
  4. Bao, F., Brown, A., Dekaban, G.A., Omana, V., and Weaver, L.C. CD11d integrin blockade reduces the systemic inflamma-tory response syndrome after spinal cord injury. Exp. Neurol. (2011) 231:272-283.
  5. Bao, F., Omana, V., Brown, A., and Weaver, L.C. The systemic inflammatory response after spinal cord injury in the rat is decreased by alpha4beta1 integrin blockade. J. Neurotrauma (2012) 29:1626-1637.
  6. Campbell, S.J., Zahid, I., Losey, P., Law, S., Jiang, Y., Bilgen, M., van Rooijen, N., Morsali, D., Davis, A.E., and Anthony, D.C. Liver Kupffer cells control the magnitude of the inflammatory response in the injured brain and spinal cord. Neuropharmacology (2008) 55:780-787.
  7. Charlton, M.R., Burns, J.M., Pedersen, R.A., Watt, K.D., Heimbach, J.K., and Dierkhising, R.A. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology (2011) 141:1249-1253.
  8. Cragg, J.J., Stone, J.A., and Krassioukov, A.V. Management of cardiovascular disease risk factors in individuals with chronic spinal cord injury: an evidence-based review. J. Neurotrauma (2012) 29:1999-2012.
  9. Farrell, G.C., and Larter, C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology (2006) 43:99-112.
  10. Farrell, G.C., van Rooyen, D., Gan, L., and Chitturi, S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver (2012) 6:149-171.
  11. Fleming J.C., Bailey C.S., Hundt H., Gurr K.R., Bailey S.I., Cepinskas G., Lawendy A.R., and Badhwar, A. Remote inflammatory response in liver is dependent on the segmental level of spinal cord injury. J. Trauma Acute Care Surg. (2012) 72:1194-1202.
  12. Gibson, A.E., Buchholz, A.C., and Martin Ginis, K.A. C-Reactive protein in adults with chronic spinal cord injury: increased chronic inflammation in tetraplegia vs paraplegia. Spinal Cord (2008) 46:616-621.
  13. Gris, D., Hamilton, E.F., and Weaver, L.C. The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp. Neurol. (2008) 211:259-270.
  14. Huang, C.C., Liu, C.W., Weng, M.C., Chen, T.W., and Huang, M.H. Association of C-reactive protein and insulin resistance in patients with chronic spinal cord injury. J. Rehabil. Med. (2008) 40:819-822.
  15. Imai, K., Kadowaki, T., Aizawa, Y., and Fukutomi, K. Problems in the health management of persons with spinal cord injury. J. Clin. Epidemiol. (1996) 49:505-510.
  16. Khasanova D.A., Teshaev S.J. Effects of genetically modified products on the human body (literature review), (2020) 5(45):5-19.
  17. Lee, M.Y., Myers, J., Hayes, A., Madan, S., Froelicher, V.F., Perkash, I., and Kiratli, B.J. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury. J. Spinal Cord Med. (2005) 28:20-25.
  18. Manns, P.J., McCubbin, J.A., and Williams, D.P. Fitness, inflammation, and the metabolic syndrome in men with paraplegia. Arch. Phys. Med. Rehabil. (2005) 86:1176-1181.
  19. Nelson, M.D., Widman, L.M., Abresch, R.T., Stanhope, K., Havel, P.J., Styne, D.M., and McDonald, C.M. Metabolic syndrome in adolescents with spinal cord dysfunction. J. Spinal Cord Med. (2007) 30(1):127-139.
  20. Paschos, P., and Paletas, K. Nonalcoholic fatty liver disease and metabolic syndrome. Hippokratia (2009) 13:9-19.

file

download